Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:http://oc1dean.blogspot.com/2010/11/my-background-story_8.html

Monday, August 1, 2016

Joshua Gordon Named New Head of NIMH - National Institute of Mental Health

And if survivors had anything even remotely approaching a great stroke association we would be approaching him to see what science is needed to prevent the likely depression from stroke. But we don't and the opportunity will be fucking lost like everything to do with stroke research. And the boards of directors don't have enough sense to make this an objective of the president.
https://danablog.org/2016/08/01/joshua-gordon-named-new-head-of-nimh/
In late July, the National Institutes of Health (NIH) announced that it had finally completed its nearly year-long search for a new director of the National Institute of Mental Health (NIMH). Francis Collins, M.D., Ph.D., said that the agency had selected Joshua Gordon, M.D., Ph.D., currently an associate professor of psychiatry at Columbia University, to take the helm of the $1.5 billion federal agency governing mental health research, replacing former director Thomas Insel. He is expected to start in September.

In the press release announcing the selection, Collins said, “Josh is a visionary psychiatrist and neuroscientist with deep experience in mental health research and practice. He is exceptionally well qualified to lead the NIMH research agenda to improve mental health and treatments for mental illnesses. We’re thrilled to have him join the NIH leadership team.
Gordon, whose research program focused on integrative genetic models of psychiatric disease, spoke with the Dana Foundation about why he wanted to take on this new role in his career, the importance of collaboration and communication, and where he hopes to see the agency go under his leadership.

You’ve had quite a bit of success in academia. Why throw your hat in the ring to lead NIMH?
It’s a really exciting time in psychiatric neuroscience. And such an exciting time comes with a lot of possibilities—but also a lot of responsibilities for the field. In order to pursue those possibilities, with attention to tailoring neuroscience and basic research to really make a difference in people’s lives, requires a lot of thought and planning. So playing a role in how best to do that thought and planning moving forward is an exciting thing to take part in.

More at link.

No comments:

Post a Comment